title: Prevalence of Subclinical Hypothyroidism in Patients with End-Stage Renal Disease and the Role of Serum Albumin: A Cross-Sectional Study from South India.
abstract: BACKGROUND/AIM: Subclinical hypothyroidism (SCH) and end-stage renal disease (ESRD) are independent risk factors for cardiovascular mortality. We aimed to study the prevalence of SCH in ESRD patients and assessed its associated risk factors.  METHODS: This cross-sectional study was conducted at 2 tertiary-care centers in Chennai, India, over a 3-year period. The study group comprised 137 patients with ESRD on thrice weekly regular maintenance hemodialysis. Free thyroxine (FT(4)) and thyroid-stimulating hormone (TSH) were measured using an electrochemiluminescence immunoassay. SCH was defined as TSH ranging between 4.5 and 10 mIU/l with normal FT(4) (0.93-1.7 ng/dl). Patients with overt hypothyroidism, SCH and overt hyperthyroidism, those on medications affecting thyroid function and pregnant women were excluded from the study.  RESULTS: Of 137 ESRD patients (mean age: 43 ± 13.38 years), 107 were males (78.1%), 45 diabetics (32.8%), 127 hypertensives (92.7%), and 38 smokers (27.7%). Prevalence of SCH was 24.8%. In unadjusted (OR: 3.37, 95% CI: 1.91-5.21) and adjusted (for age, gender, HbA(1C), and albumin/creatinine ratio; OR: 3.11, 95% CI: 2.15-4.98) logistic regression analysis, serum albumin was significantly associated with SCH. Further, multiple linear regression identified that for every 1 g/dl drop in serum albumin TSH increased by 4.61 mIU/l (95% CI: 2.75-5.92).  CONCLUSION: We observed a high prevalence of SCH in our ESRD patients. Also, serum albumin was significantly associated with SCH in our study.
authors.affiliation: Sri Ramachandra University, Chennai, India.
authors.forename: Ghanshyam Palamaner Subash
authors.initials: GP
authors.lastname: Shantha
authors.forename: Anita Ashok
authors.initials: AA
authors.lastname: Kumar
authors.forename: Viraj
authors.initials: V
authors.lastname: Bhise
authors.forename: Rohit
authors.initials: R
authors.lastname: Khanna
authors.forename: Kamesh
authors.initials: K
authors.lastname: Sivagnanam
authors.forename: Kuyilan Karai
authors.initials: KK
authors.lastname: Subramanian
references.citation: Endocr Pract. 2002 Nov-Dec;8(6):457-69
references.pmid: 15260011
references.citation: Kidney Int. 2005 Mar;67(3):1047-52
references.pmid: 15698444
references.citation: Ann Intern Med. 1973 Oct;79(4):500-4
references.pmid: 4201224
references.citation: Ann Intern Med. 1999 Mar 16;130(6):461-70
references.pmid: 10075613
references.citation: Endocr Rev. 1996 Feb;17(1):45-63
references.pmid: 8641223
references.citation: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003419
references.pmid: 17636722
references.citation: Kidney Int Suppl. 2003 Feb;(83):S86-9
references.pmid: 12864881
references.citation: Nephron Clin Pract. 2009;111(3):c197-203; discussion c203
references.pmid: 19194110
references.citation: Am J Nephrol. 2008;28(6):908-13
references.pmid: 18580053
references.citation: Med Clin North Am. 1985 Sep;69(5):849-61
references.pmid: 2997556
references.citation: Kidney Int. 1985 Sep;28(3):541-9
references.pmid: 3934453
references.citation: Am J Nephrol. 2009;29(6):620-5
references.pmid: 19151549
references.citation: Am J Physiol. 1997 May;272(5 Pt 2):F648-53
references.pmid: 9176376
references.citation: J Clin Invest. 1977 Sep;60(3):522-34
references.pmid: 408377
references.citation: Clin J Am Soc Nephrol. 2008 Sep;3(5):1296-300
references.pmid: 18550654
references.citation: Neth J Med. 2008 Dec;66(11):483-5
references.pmid: 19075315
references.citation: Nephrology (Carlton). 2009 Apr;14(3):345-9
references.pmid: 19207865
references.citation: J Endocrinol Invest. 2004 Nov;27(10):897-903
references.pmid: 15762035
references.citation: Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S80-4
references.pmid: 11576928
references.citation: Int J Med Sci. 2008;5(6):366-70
references.pmid: 19015744